Видео ютуба по тегу Breast Cancer Symposium

TROPION-PanTumor01: datopotamab deruxtecan in advanced HER2+ breast cancer
TROPION-PanTumor01: datopotamab deruxtecan in advanced HER2+ breast cancer
Dr. Shom Goel | San Antonio Breast Cancer Symposium 2022 | General Session
Dr. Shom Goel | San Antonio Breast Cancer Symposium 2022 | General Session
Почему онкологи в восторге от этих новых клинических испытаний методов лечения рака груди #Исслед...
Почему онкологи в восторге от этих новых клинических испытаний методов лечения рака груди #Исслед...
SABCS 2022: Dr. Andrea Barrio | View From The Trenches
SABCS 2022: Dr. Andrea Barrio | View From The Trenches
Circulating Tumor DNA in Breast Cancer and New Data from the San Antonio Breast Cancer Symposium
Circulating Tumor DNA in Breast Cancer and New Data from the San Antonio Breast Cancer Symposium
The Predictive Power of the Breast Cancer Index (H/I) Biomarker-SABCS 2022
The Predictive Power of the Breast Cancer Index (H/I) Biomarker-SABCS 2022
BREAST CANCER SYMPOSIUM TAKEAWAYS & NUTRITION GUIDANCE | by Cancer Education & Research Institute
BREAST CANCER SYMPOSIUM TAKEAWAYS & NUTRITION GUIDANCE | by Cancer Education & Research Institute
Highlights from the 2020 San Antonio Breast Cancer Symposium with Virginia Kaklamani, MD, DSc
Highlights from the 2020 San Antonio Breast Cancer Symposium with Virginia Kaklamani, MD, DSc
Breast Cancer Awareness Symposium 🎀 Pink OCTOBER 🌸 #Nishtar🌷
Breast Cancer Awareness Symposium 🎀 Pink OCTOBER 🌸 #Nishtar🌷
Nanomedicine Workshop - Brazilian Breast Cancer Symposium
Nanomedicine Workshop - Brazilian Breast Cancer Symposium
Краткий обзор SABCS: Результаты исследования BOOG 2013-08
Краткий обзор SABCS: Результаты исследования BOOG 2013-08
New drug approvals for metastatic breast cancer
New drug approvals for metastatic breast cancer
I-SPY2: early treatment symptoms predict pCR in high-risk breast cancer
I-SPY2: early treatment symptoms predict pCR in high-risk breast cancer
Triple-Negative Breast Cancer May Have New Treatment Option
Triple-Negative Breast Cancer May Have New Treatment Option
Remaining questions surrounding HER2-low breast cancer – how low can you go?
Remaining questions surrounding HER2-low breast cancer – how low can you go?
UC Health prepares for free breast cancer conference
UC Health prepares for free breast cancer conference
Dr. Rinath Jeselsohn | San Antonio Breast Cancer Symposium 2022
Dr. Rinath Jeselsohn | San Antonio Breast Cancer Symposium 2022
Dr. Siddhartha Yadav | San Antonio Breast Cancer Symposium 2022 | General Session
Dr. Siddhartha Yadav | San Antonio Breast Cancer Symposium 2022 | General Session
6th Annual International Breast Cancer Conference & Precision Oncology 2022 | 18th November - Hall B
6th Annual International Breast Cancer Conference & Precision Oncology 2022 | 18th November - Hall B
SABCS 2022: Dr. Melinda Telli | Year in Review
SABCS 2022: Dr. Melinda Telli | Year in Review
Exploring patient-derived xenografts for breast cancer research
Exploring patient-derived xenografts for breast cancer research
SABCS 2022 - Exact Sciences Announces Data Supporting Future of Breast Cancer Care Continuum
SABCS 2022 - Exact Sciences Announces Data Supporting Future of Breast Cancer Care Continuum
Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General Session
Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General Session
Day-2: 7th Emirates Breast Pathology and Breast Cancer Conference | May 30-31, 2021
Day-2: 7th Emirates Breast Pathology and Breast Cancer Conference | May 30-31, 2021
UCSF Bay Area Breast Cancer Forum:
UCSF Bay Area Breast Cancer Forum: "Updates from San Antonio Breast Cancer Symposium 2023"